In contrast, McArthur GA et al. reported dramatic clinical responses in DFSP patients whose tumors expressed relatively low levels of activated PDGFRB, as determined by Western blot analysis of frozen tumor specimens collected before treatment [35]. The gene discussed is PDGFRB; the disease is neoplasm.